Literature DB >> 25552810

Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis.

Maqsood M Elahi1, Charles H Choi1, Subbareddy Konda1, Jay G Shake1.   

Abstract

This report describes a patient's self-substitution of nattokinase for the vitamin K antagonist warfarin after aortic valve replacement with a mechanical prosthesis. Nattokinase is an enzyme derived from a popular fermented soybean preparation in Japan (natto), which has fibrinolytic properties and is gaining popularity in nontraditional health journals and nonmedical health websites as an over-the-counter thrombolytic. After nearly a year of use of nattokinase without warfarin, the patient developed thrombus on the mechanical valve and underwent successful repeat valve replacement. We believe this is the first documented case of nattokinase being used as a substitute for warfarin after valve replacement, and we strongly discourage its use for this purpose.

Entities:  

Year:  2015        PMID: 25552810      PMCID: PMC4264722          DOI: 10.1080/08998280.2015.11929198

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

1.  Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase.

Authors:  H Sumi; H Hamada; K Nakanishi; H Hiratani
Journal:  Acta Haematol       Date:  1990       Impact factor: 2.195

2.  Directed evolution improves the fibrinolytic activity of nattokinase from Bacillus natto.

Authors:  Cai Yongjun; Bao Wei; Jiang Shujun; Weng Meizhi; Jia Yan; Yin Yan; Zheng Zhongliang; Zou Goulin
Journal:  FEMS Microbiol Lett       Date:  2011-12       Impact factor: 2.742

3.  Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

Authors:  C B Granger; R Becker; R P Tracy; R M Califf; E J Topol; K S Pieper; A M Ross; S Roth; C Lambrew; E G Bovill
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

4.  Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects.

Authors:  Chien-Hsun Hsia; Ming-Ching Shen; Jen-Shiou Lin; Yao-Ke Wen; Kai-Lin Hwang; Thau-Ming Cham; Nae-Cherng Yang
Journal:  Nutr Res       Date:  2009-03       Impact factor: 3.315

5.  Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLIT-FLITE randomized, controlled trial.

Authors:  M R Cesarone; G Belcaro; A N Nicolaides; A Ricci; G Geroulakos; E Ippolito; R Brandolini; G Vinciguerra; M Dugall; M Griffin; I Ruffini; G Acerbi; M Corsi; N H Riordan; S Stuard; P Bavera; A Di Renzo; J Kenyon; B M Errichi
Journal:  Angiology       Date:  2003 Sep-Oct       Impact factor: 3.619

6.  A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet.

Authors:  H Sumi; H Hamada; H Tsushima; H Mihara; H Muraki
Journal:  Experientia       Date:  1987-10-15

7.  Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery.

Authors:  Yasuhiro Suzuki; Kazunao Kondo; Yuji Matsumoto; Bing-Qing Zhao; Kenichi Otsuguro; Tetsuya Maeda; Yoshinori Tsukamoto; Tetsumei Urano; Kazuo Umemura
Journal:  Life Sci       Date:  2003-07-25       Impact factor: 5.037

8.  Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat.

Authors:  M Fujita; K Hong; Y Ito; R Fujii; K Kariya; S Nishimuro
Journal:  Biol Pharm Bull       Date:  1995-10       Impact factor: 2.233

9.  Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.

Authors:  P A Merlini; K A Bauer; L Oltrona; D Ardissino; A Spinola; M Cattaneo; M Broccolino; P M Mannucci; R D Rosenberg
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

  9 in total
  2 in total

1.  Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants.

Authors:  Hongjie Chen; Jiepeng Chen; Fuping Zhang; Yuanhui Li; Ronghua Wang; Qiang Zheng; Xu Zhang; Jun Zeng; Feng Xu; Yiguang Lin
Journal:  Front Cardiovasc Med       Date:  2022-08-22

Review 2.  Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases.

Authors:  Hongjie Chen; Eileen M McGowan; Nina Ren; Sara Lal; Najah Nassif; Fatima Shad-Kaneez; Xianqin Qu; Yiguang Lin
Journal:  Biomark Insights       Date:  2018-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.